Jan Zitko

24PUBLICATIONS
49CO-AUTHORS
BiomaterialsPharmacogenomicsBiologically active moleculesGenome structure and regulationCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 02, 2026
Atomic-Level Structures Reveal How a Repurposed 3‑Aminopyrazine-2-carboxamide Scaffold Inhibits Mycobacterium tuberculosis Prolyl-tRNA Synthetase.

|Feb 02, 2026
Targeting Mycobacterium tuberculosis: The Role of Alkyl Substitution in Pyrazinamide Derivatives.

Martin Juhás, Ghada Bouz, Luping Pang

|Aug 29, 2025
Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of (E)-N'-Benzylidenepyrazine-2-Carbohydrazides and their Derivatives.

Priam-Amedeo Houngbedji, Daria Elżbieta Nawrot, Ondřej Janďourek

|Jan 21, 2025
Antimicrobial and Antiproliferative Properties of 2-Phenyl-N-(Pyridin-2-yl)acetamides.

Daria Nawrot, Barbora Koutníková, Ondřej Janďourek

|Jan 13, 2025
The discovery of a new nonbile acid modulator of Takeda G protein-coupled receptor 5: An integrated computational approach.

Rudy Salam, Michael Bakker, Mária Krutáková

|May 06, 2024
A hit expansion of 3-benzamidopyrazine-2-carboxamide: Toward inhibitors of prolyl-tRNA synthetase with antimycobacterial activity.

Vinod Sukanth Kumar Pallabothula, Nechirwan Taimur Abdalrahman, Matteo Mori

Pageof 4

Frequent Collaborators

16 joint publications

Ondřej Janďourek

12 joint publications

Klára Konečná

10 joint publications

Martin Doležal

9 joint publications

Martin Juhás